Raloxifene Hydrochloride

Product NDC
70518-2994
11-digit product format
705182994
Labeler code
70518
Product ID
70518-2994_ba4bd825-6c23-00e4-e053-2995a90a2b4c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Raloxifene Hydrochloride
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA078193
Marketing category
ANDA
Marketing start
2021-01-17
Marketing end
0000-00-00
Substance
RALOXIFENE HYDROCHLORIDE
Active strength
60 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2994-02023-03-14C16284748780-1f386c64a-1fc3-0266-e053-dadaa90a7c1a54543440-0ea3-4244-a789-b96c996c3fc9
70518-2994-02023-01-30C16284748780-1f386c64a-1fc3-0266-e053-dadaa90a7c1a54543440-0ea3-4244-a789-b96c996c3fc9

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2994-07051829940030 POUCH in 1 BOX (70518-2994-0) > 1 TABLET, FILM COATED in 1 POUCH (70518-2994-1) 30 pouch2021-01-170000-00-00NoNoCurrent